Latest Troponin test Stories
Silicon BioDevices 'Lab-in-the-Hand' Previewed at 45th Annual Oak Ridge Conference BALTIMORE, April 18, 2012 /PRNewswire/ -- Silicon BioDevices, based in Berkeley, Calif., today presented the results of a pivotal benchmark study of its digital handheld device for high-sensitivity measurement of cardiac troponin-I, a protein found in the heart muscle used to identify heart tissue damage in patients suspected of having a heart attack. The study showed that the totally integrated,...
WASHINGTON, March 8, 2013 /PRNewswire-USNewswire/ -- Most of us know about lab tests for high cholesterol and how important they are in helping prevent and control heart disease. But lab tests do much more--helping physicians prevent heart problems, diagnose heart attacks, and manage heart conditions. Diagnosing heart attacks One of the most important roles is helping physicians diagnose heart attacks, even when the symptoms are unclear. Doctors often use a test that measures the...
ABBOTT PARK, Ill., Jan. 9, 2013 /PRNewswire/ -- An estimated 17 million people throughout the world die annually of cardiovascular diseases, specifically heart attacks or strokes.(1) Time is a critical factor in diagnosing and treating people who may be having a potential heart attack. To aid physicians in detecting heart attacks sooner, Abbott announced today CE Marking (Conformite Europeenne) for the ARCHITECT STAT High Sensitive Troponin-I Assay. Diagnosing Potential...
ABBOTT PARK, Ill., Dec. 13, 2012 /PRNewswire/ -- Acute chest pain is one of the most common reasons people seek emergency care, and time is a critical factor in diagnosing and treating people who may be having a heart attack. The latest generation of diagnostic tests in development is expected to provide information that will be important to patient outcomes, potentially reducing the time to diagnosis of heart attacks by several hours. The specific performance characteristics of...
LONDON, Dec. 12, 2012 /PRNewswire/ -- Cardiovascular disease (CVD) is the main cause of death in the EU, killing over 2 million people annually and costing the economy nearly EUR192 billion. Prevention, through constant monitoring of heart health, is seen as the best way to tackle this high death rate. The most accurate way of monitoring heart health is through cardiac marker testing. Regular monitoring of cardiac health through brain natriuretic peptide (BNP) testing is being...
A simple blood test can help identify people who are at high risk of dying within the month after non-cardiac surgery, a study by McMaster University researchers has found. Knowing who is at risk through the test called Troponin T (a protein marker of heart injury) can help physicians target patients who need enhanced observation or interventions, says the major study published today in the Journal of the American Medical Association. Currently, troponin levels are not commonly measured...
Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT) in clinical practice has helped clinicians to detect and treat patients with acute myocardial...
TOKYO, June 14, 2011 /PRNewswire/ -- Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST® cTnI-II (cardiac Troponin I) diagnostic test, clearing the way for its sale in the United States. The test is designed to be used with the PATHFAST analysis system, a unique, self-contained, bench-top chemi-luminescence immunoanalyzer that rapidly measures concentrations of...
BERLIN, May 18, 2011 /PRNewswire/ -- Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary syndromes. Troponin is a protein found inside of heart cells that is released when they are damaged by ischemia or reduced blood supply. Cardiac troponin is regarded by clinicians as one of...
(Ivanhoe Newswire) -- Novel research illustrates that elevated levels of cardiac troponin T (cTnT) or I (cTnI) in patients who had angioplasty indicate a higher risk of all-cause mortality in addition to long-term harmful events such as heart attack. Routine monitoring of these protein levels subsequent to nonemergent percutaneous coronary intervention (PCI) might improve long-term outcomes for these patients.According to the National Heart, Lung and Blood Institute, more than one million...
